Cargando…

Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs

Amyloid-β peptides, through highly sophisticated enzymatic machinery, are universally produced and released in an action potential synchronized manner into the interstitial fluids in the brain. Yet no native functions are attributed to amyloid-β. The amyloid-β hypothesis ascribes just neurotoxicity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Rajnish, Nordberg, Agneta, Darreh-Shori, Taher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949388/ https://www.ncbi.nlm.nih.gov/pubmed/26525916 http://dx.doi.org/10.1093/brain/awv318

Ejemplares similares

Soluble Aβ42 Acts as Allosteric Activator of the Core Cholinergic Enzyme Choline Acetyltransferase
por: Kumar, Amit, et al.
Publicado: (2018)

Allosteric Binding Sites of Aβ Peptides on the Acetylcholine Synthesizing Enzyme ChAT as Deduced by In Silico Molecular Modeling
por: Baidya, Anurag TK, et al.
Publicado: (2022)

Fibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation
por: Malmsten, Linn, et al.
Publicado: (2014)

CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer’s Disease
por: Karami, Azadeh, et al.
Publicado: (2019)

Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer’s Disease Status and Risk Genotype
por: Lana, Erica, et al.
Publicado: (2019)

CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment
por: Karami, Azadeh, et al.
Publicado: (2021)

Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization
por: Kumar, Rajnish, et al.
Publicado: (2016)

Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening
por: Kumar, Rajnish, et al.
Publicado: (2017)

Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas
por: Sinclair, Lindsey Isla, et al.
Publicado: (2019)

Increased Endogenous GDNF in Mice Protects Against Age-Related Decline in Neuronal Cholinergic Markers
por: Mitra, Sumonto, et al.
Publicado: (2021)

β-Amyloid 1-42 Oligomers Impair Function of Human Embryonic Stem Cell-Derived Forebrain Cholinergic Neurons
por: Wicklund, Linn, et al.
Publicado: (2010)

Phenotypic Displays of Cholinergic Enzymes Associate With Markers of Inflammation, Neurofibrillary Tangles, and Neurodegeneration in Pre- and Early Symptomatic Dementia Subjects
por: Teitsdottir, Unnur D., et al.
Publicado: (2022)

Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells
por: Reyes Barcelo, Adriana A, et al.
Publicado: (2009)

Amyloid Beta Peptide (Aβ(1-42)) Reverses the Cholinergic Control of Monocytic IL-1β Release
por: Richter, Katrin, et al.
Publicado: (2020)

Increased Active OMI/HTRA2 Serine Protease Displays a Positive Correlation with Cholinergic Alterations in the Alzheimer’s Disease Brain
por: Darreh-Shori, Taher, et al.
Publicado: (2018)

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease
por: Kadir, Ahmadul, et al.
Publicado: (2011)

Cholinergic neurons—keeping check on amyloid β in the cerebral cortex
por: Ovsepian, Saak V., et al.
Publicado: (2013)

Regulated Extracellular Choline Acetyltransferase Activity— The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway
por: Vijayaraghavan, Swetha, et al.
Publicado: (2013)

Fast Alpha Activity in EEG of Patients With Alzheimer’s Disease Is Paralleled by Changes in Cognition and Cholinergic Markers During Encapsulated Cell Biodelivery of Nerve Growth Factor
por: Eyjolfsdottir, Helga, et al.
Publicado: (2022)

Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity
por: Sala, Arianna, et al.
Publicado: (2020)

Soluble amyloid-β precursor peptide does not regulate GABA(B) receptor activity
por: Rem, Pascal Dominic, et al.
Publicado: (2023)

Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
por: Campos-Peña, Victoria, et al.
Publicado: (2022)

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device
por: Eyjolfsdottir, Helga, et al.
Publicado: (2016)

Revisiting the Idea That Amyloid-β Peptide Acts as an Agonist for P2X7
por: Bibič, Lučka, et al.
Publicado: (2020)

Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia
por: Leyhe, Thomas, et al.
Publicado: (2013)

Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
por: Cui, Su-Ying, et al.
Publicado: (2019)

Cholinergic receptor, nicotinic, alpha 7 as a target molecule of Arctic mutant amyloid β
por: Sawamura, Naoya, et al.
Publicado: (2018)

Soluble γ-Secretase Modulators Selectively Inhibit the Production of the 42-Amino Acid Amyloid β Peptide Variant and Augment the Production of Multiple Carboxy-Truncated Amyloid β Species
por: Wagner, Steven L., et al.
Publicado: (2014)

Assembly of Peptides Derived from β-Sheet Regions of β-Amyloid
por: Truex, Nicholas L., et al.
Publicado: (2016)

Coassembly of Peptides Derived from β-Sheet Regions of β-Amyloid
por: Truex, Nicholas L., et al.
Publicado: (2016)

Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides
por: Huang, Yaliang, et al.
Publicado: (2021)

Key Residue for Aggregation of Amyloid-β Peptides
por: Itoh, Satoru G., et al.
Publicado: (2022)

Common molecular mechanism of amyloid pore formation by Alzheimer’s β-amyloid peptide and α-synuclein
por: Di Scala, Coralie, et al.
Publicado: (2016)

Aβ-40 Y10F Increases βfibrils Formation but Attenuates the Neurotoxicity of Amyloid-β Peptide
por: Dai, Xueling, et al.
Publicado: (2012)

Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
por: Trysberg, Estelle, et al.
Publicado: (2004)

Tailoring Hydrophobic Interactions between Probes and Amyloid-β Peptides for Fluorescent Monitoring of Amyloid-β Aggregation
por: Kim, Sonam, et al.
Publicado: (2018)

Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
por: Braun, Gabriel A., et al.
Publicado: (2022)

The Amyloid Forming Peptides Islet Amyloid Polypeptide and Amyloid β Interact at the Molecular Level
por: Wang, Ye, et al.
Publicado: (2021)

Influence of a genetic variant of CHAT gene over the profile of plasma soluble ChAT in Alzheimer disease
por: Rocha-Dias, Patricia Fernanda, et al.
Publicado: (2020)

Soluble amyloid-β, effect on cerebral arteriolar regulation and vascular cells
por: Dietrich, Hans H, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_osfna25uv9qh7ba7d156bn1len